查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948940

血液凝固管市场按材料、管材类型、应用、添加剂、销售管道和最终用户划分，全球预测（2026-2032年）

Clotting Tube Market by Material, Tube Type, Application, Additive, Sales Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，血液凝固管市场价值将达到 13 亿美元，到 2026 年将成长至 13.6 亿美元，到 2032 年将达到 19.2 亿美元，年复合成长率为 5.71%。

主要市场统计数据
基准年 2025 13亿美元
预计年份：2026年 13.6亿美元
预测年份：2032年 19.2亿美元
复合年增长率 (%) 5.71%

血液凝固管的选择及其与分析前变数交互作用对诊断准确性的临床和操作重要性

血液凝固管在临床诊断中发挥至关重要的作用，是患者检体与诊断实验室接触的第一道防线。本文重点阐述了试管选择对后续分析准确性和工作流程效率的显着影响，并着重于操作和临床层面的依赖性。从分析前处理到离心和检测适用性，材料成分、试管形态和添加剂化学性质的细微差异都可能对检体完整性和检测可靠性产生重大影响。

自动化技术、添加剂化学和供应链韧性的进步正在重新定义凝血管的设计要求和检查室检验的优先事项。

止血管领域正经历变革性的转变，这得益于检查室自动化、监管要求和材料科学等多面向因素的共同作用。创新不再局限于製造公差的渐进式改进，而是延伸至添加剂和表面化学性质的重新设计，以优化凝血动力学并保持分析物的稳定性。这些进步直接满足了集中式和分散式检查环境中对更快结果和更高通量的需求。

评估新兴关税趋势如何推动临床供应链中的采购多元化、区域生产转移和跨职能检验策略。

2025年美国关税趋势正对临床耗材生态系统内的筹资策略和供应链规划施加显着压力。关税调整正在改变到岸成本和前置作业时间预期，促使采购机构重新评估供应商关係、库存缓衝和采购区域，以确保临床服务的连续性。为此，风险规避型采购负责人优先考虑供应商多元化和更长的资格认证週期，而非寻找替代製造商。

将材料选择、管材结构、添加剂化学和最终用户需求与实际验证和采购方案连结起来的详细細項分析

细分市场分析揭示了材料选择、管材结构、应用需求、添加剂化学、销售管道和终端用户需求等方面的技术差异化和采购重点交叉点。基于材料，决策者会权衡玻璃管和塑胶管的优缺点，玻璃管的优点在于其化学惰性和光学透明度，而塑胶管的优点在于其抗衝击性、轻质以及与自动化加工的兼容性。基于管材类型，封闭式系统设计更受污染控制和生物安全方面的青睐，而开放式管材则仍主要应用于手动工作流程和传统製程。

美洲、欧洲、中东和非洲以及亚太地区的区域营运和监管差异将决定验证、采购和实施管道。

区域趋势正在影响美洲、欧洲、中东和非洲以及亚太地区的供应、验证要求和实施时间表。在美洲，集中式实验室网路和大型医院系统推动了对高通量试管和严格低温运输检验物流的需求。采购週期受到整合采购集团和临床检验标准的影响，这些标准强调连网设施间的可重复性。同时，在欧洲、中东和非洲地区，法规环境和采购方式正在分化，区域分销商在确保符合当地的灭菌和标籤要求方面发挥关键作用。

积层製造技术、生产稳定性、监管支援和供应链韧性正成为领先管材製造商之间的竞争优势。

竞争格局由那些将辅料化学技术专长与完善的品质系统和透明的供应链相结合的製造商和供应商所塑造。主要企业强调可重复的凝块形成、辅料行为的低变异性以及严格的无菌检验，以支持临床应用。策略差异化优势包括全面的技术文件、在常用分析设备上进行的兼容性测试以及为区域核准提供的快速监管支援。

产业领导者应实施切实可行的营运、采购和检验策略，以提高临床接受度并确保供应的连续性

产业领导者可以采取实际措施来增强供应连续性、加快临床验收并减少产品变更相关的验证阻力。首先，应投资于跨职能验证机制，整合采购、品质和临床团队，在反映最终使用者工作流程的受控通讯协定下评估新的试管变体。这些机制应包括凝血、溶血率和检测相容性的标准化验收标准，以简化联网检查室的核准决策。

结合关键相关人员访谈、技术文件审查和检验为重点的用例，采用综合研究途径，确保研究结果具有可操作性和可复现性。

本研究基于临床实验室主任、采购人员和生产品质专家的访谈，并辅以技术文献、监管指导文件和产品规格的二次查阅。主要研究着重于检查室工作流程、检验要求和采购标准，旨在了解具有代表性的最终使用者群体在实际应用中的限制和偏好。二次资料则提供了添加剂化学、材料性能和灭菌方法的背景资讯。

整合临床、营运和供应链影响，强调策略验证、文件记录和采购对于可靠诊断的重要性。

总之，血液凝固检验管是诊断价值链中至关重要却又常被忽视的环节，其材料、管材设计和添加剂化学成分的选择会对检测性能、检查室工作流程效率和供应连续性产生切实的影响。技术创新、监管细则和贸易趋势的累积效应正在重塑检查室和供应商的产品开发、采购和验证方式。积极将跨职能检验方法与供应商多元化策略结合的机构，将更有能力在不断变化的营运环境中保持临床信心。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 销售管道分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 按材料分類的血液凝固管市场

  • 玻璃
  • 塑胶

9. 按管型分類的血液凝固管市场

  • 闭型
  • 开放型

第十章 按应用分類的血液凝固管市场

  • 临床化学
    • 胆固醇
    • 葡萄糖
    • 尿酸
  • 血液凝固检验
    • 活化部份凝血活酵素时间
    • 凝血酶原时间
    • 凝血酶时间
  • 免疫检测
    • 荷尔蒙测量
    • 肿瘤标记

第十一章 以添加剂分類的血液凝固管市场

  • 血清凝血促进剂
    • 微粉化二氧化硅
    • 硅涂层
  • 柠檬酸钠

第十二章 血液凝固管市场销售管道

  • 在线的
  • 离线

第十三章 按最终用户分類的血液凝固管市场

  • 学术和参考机构
  • 诊断实验室
  • 医院
  • 研究所

第十四章 各地区血液凝固管市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 血液凝固管市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国血液凝固管市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国血液凝固管市场

第十八章 中国血液凝固管市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AN PHARMA
  • AV Consumables
  • ACEE Tubes Pvt Ltd
  • Ajosha BIoTeknik Pvt Ltd
  • Apex Bio-medicals
  • BD（Becton, Dickinson and Company）
  • BDK Life Science
  • Bio-x
  • Cardinal Health Inc.
  • CML BIoTech Pvt Ltd
  • Diagnostic Care And Trading Pvt Ltd
  • Fusion BIoTech
  • Greiner Bio-One
  • Human Biomedicals LLP
  • Labtech Disposables
  • Levram Life Sciences Pvt Ltd
  • MK Plast
  • Nasmed Diagnostics Pvt. Ltd.
  • Quantum Biomedicals
  • Raj Biosis Private Limited
Product Code: MRR-4F7A6D4FB8F8

The Clotting Tube Market was valued at USD 1.30 billion in 2025 and is projected to grow to USD 1.36 billion in 2026, with a CAGR of 5.71%, reaching USD 1.92 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.30 billion
Estimated Year [2026] USD 1.36 billion
Forecast Year [2032] USD 1.92 billion
CAGR (%) 5.71%

Framing the clinical and operational importance of clotting tube selection and the interplay of pre-analytical variables that determine diagnostic fidelity

Clotting tubes occupy a foundational role in clinical diagnostics, serving as the initial point of interaction between patient specimens and the diagnostic laboratory. The introduction to this subject emphasizes the operational and clinical dependencies that make tube selection consequential for downstream analytical accuracy and workflow efficiency. From pre-analytical handling to centrifugation and assay compatibility, subtle differences in material composition, tube geometry, and additive chemistry can materially influence specimen integrity and assay reliability.

Early sections of this analysis contextualize the current technological trajectory by linking laboratory automation trends to demands for consistent sample quality. As laboratories expand throughput and adopt integrated analyzers, they increasingly prioritize tubes that minimize hemolysis, enable stable clot formation where required, and maintain compatibility with robotic handling systems. At the same time, evolving regulatory scrutiny and heightened expectations for traceability and contamination control are shaping procurement specifications.

Transitioning from clinical drivers to supply-side dynamics, the introduction also highlights the interplay between manufacturing capabilities, additive innovations, and logistical considerations such as cold chain resilience and sterilization validation. Together, these factors frame the strategic questions that laboratory directors, procurement leaders, and product development teams must address when evaluating clotting tube options.

How advances in automation, additive chemistry, and supply chain resilience are redefining clotting tube design requirements and laboratory validation priorities

The clotting tube landscape is undergoing transformative shifts driven by converging forces in laboratory automation, regulatory expectations, and material science. Innovation is no longer limited to incremental improvements in manufacturing tolerances; rather, it encompasses reengineering additives and surface chemistries to optimize clot formation kinetics while preserving analyte stability. These advances respond directly to the need for faster turnaround times and higher throughput across centralized and decentralized testing environments.

Concurrently, laboratory workflows are migrating toward integrated platforms where sample containers must meet stringent dimensional and material specifications to ensure reliable automation. This practical requirement is accelerating the adoption of tubes with design features that reduce carousel friction, improve sealing reliability, and support barcode-based traceability. In parallel, concerns about supply chain resilience have incentivized manufacturers to diversify material sourcing and to qualify alternative polymer blends or glass formulations that maintain performance under varying sterilization protocols.

Another significant shift is the increasing emphasis on compatibility across a broad spectrum of assays, from routine clinical chemistry to specialized immunoassays. As diagnostic platforms expand their test menus, demand grows for tubes that minimize cross-reactivity and matrix effects. Taken together, these transformative changes are recalibrating design priorities, procurement strategies, and validation practices across laboratory networks.

Assessing how new tariff dynamics are prompting procurement diversification, regional production shifts, and cross-functional validation strategies in clinical supply chains

Tariff policy developments in the United States for 2025 are exerting measurable pressure on procurement strategies and supply chain planning within the clinical consumables ecosystem. Tariff adjustments can alter landed costs and lead time expectations, prompting buying organizations to re-evaluate supplier relationships, inventory buffers, and sourcing geographies to maintain continuity of clinical services. In response, risk-averse buyers are prioritizing supplier diversification and longer qualification cycles for alternative manufacturers.

Beyond direct cost implications, tariff shifts influence decisions around manufacturing localization and nearshoring. Some suppliers are accelerating investments in regional production capacity or expanding distributor partnerships to mitigate tariff exposure and reduce logistical complexity. At the same time, laboratory operations face practical trade-offs between switching to locally produced variants that may have different validations and preserving continuity with incumbent products to minimize clinical risk.

Procurement teams are increasingly collaborating with clinical leadership to build formalized change-control processes that account for tariff volatility. These processes include cross-functional validation protocols, inventory contingency plans, and contractual clauses that provide pricing transparency under changing trade conditions. Ultimately, tariff dynamics are encouraging greater strategic alignment between supply chain, regulatory, and clinical stakeholders to safeguard assay performance and operational reliability.

In-depth segmentation analysis connecting material selection, tube architecture, additive chemistry, and end-user requirements to practical validation and procurement choices

Segmentation insights reveal where technical differentiation and procurement focus converge across material choices, tube architectures, application demands, additive chemistries, sales channels, and end-user needs. Based on material, decision-makers evaluate trade-offs between glass and plastic tubes, weighing glass for its chemical inertness and optical clarity against plastic for impact resistance, lighter weight, and compatibility with automated handling. Based on tube type, closed system designs are favored for contamination control and biosafety, while open system tubes remain prevalent for manual workflows and legacy processes.

Based on application, clinical chemistry use cases such as cholesterol, glucose, and uric acid testing drive expectations for serum separation efficiency and minimal analyte interference. Coagulation tests, including activated partial thromboplastin time, prothrombin time, and thrombin time, demand precise anticoagulant-performance characteristics and predictable clotting behavior during processing. Immunoassays, covering hormone assays and tumor markers, require strict control of matrix effects and low background signal, which places a premium on consistent additive behavior and surface treatments.

Based on additive, serum clot activator formulations such as micronized silica or silicone-coated surfaces are assessed for clotting time consistency and downstream assay compatibility, while sodium citrate variants at 3.2% and 3.8% concentrations are scrutinized for volumetric accuracy and citrate-to-blood ratios that affect coagulation test results. Based on sales channel, direct relationships enable tighter specification control and technical collaboration, whereas distributor channels offer breadth of reach and logistical flexibility. Based on end user, academic and reference laboratories, diagnostic laboratories, hospitals, and research institutes each prioritize different attributes, from high-throughput compatibility to traceability and batch-level quality documentation.

Regional operational and regulatory nuances across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine validation, procurement, and adoption pathways

Regional dynamics shape supply, validation requirements, and adoption timelines across the Americas, Europe Middle East & Africa, and Asia-Pacific regions. In the Americas, centralized laboratory networks and large hospital systems drive demand for high-throughput compatible tubes and stringent cold-chain validated logistics; procurement cycles are influenced by consolidated purchasing groups and clinical validation standards that emphasize reproducibility across networked sites. In contrast, Europe, Middle East & Africa presents a mosaic of regulatory environments and procurement modalities where regional distributors play a pivotal role in ensuring compatibility with localized sterilization and labeling requirements.

Asia-Pacific demonstrates accelerated investment in diagnostic infrastructure and rapid adoption of automation in urban centers, creating demand for scalable tube formats and materials that withstand variable storage and transport conditions. Across all regions, local regulatory nuances, import controls, and clinical guideline interpretations require suppliers to adapt documentation, validation support, and labeling practices accordingly. These geographic distinctions also inform decisions around inventory staging, qualification timelines, and strategic partnerships with regional manufacturers or distributors.

Therefore, stakeholders should align product development, quality assurance documentation, and supply chain strategies to accommodate the specific regulatory and operational requirements of each regional cluster, shortening time-to-adoption and reducing the friction associated with cross-border deployments.

Competitive differentiation driven by additive expertise, production consistency, regulatory support, and supply chain resilience among leading tube manufacturers

The competitive landscape is shaped by manufacturers and suppliers that combine technical know-how in additive chemistry with robust quality systems and supply chain transparency. Leading organizations emphasize reproducibility of clot formation, low variability in additive behavior, and rigorous sterilization validation to support clinical adoption. Strategic differentiators include the ability to provide comprehensive technical dossiers, compatibility testing across common analyzers, and responsive regulatory support for localized approvals.

Partnership models vary from integrated direct-supply relationships that facilitate co-development and rapid specification alignment to distributor-led channels that focus on logistical reach and regional regulatory translation. Companies investing in in-house material science expertise and automated production lines tend to offer greater consistency in dimensional tolerances and surface treatment uniformity, which reduces the burden of site-level validation. Additionally, firms that maintain multi-site production or diversified sourcing can better mitigate single-point failures and adapt to changing trade conditions.

Innovation focus among competitors increasingly centers on additive formulations that shorten clotting times without introducing assay interference, tube geometries optimized for automated handling, and traceability features such as scannable identifiers embedded in the container design. Collectively, these capabilities influence procurement evaluations and the speed at which new products are accepted by clinical laboratories.

Actionable operational, sourcing, and validation strategies that industry leaders should implement to enhance clinical acceptance and safeguard supply continuity

Industry leaders can take concrete steps to strengthen supply continuity, accelerate clinical acceptance, and reduce validation friction stemming from product changes. First, invest in cross-functional validation frameworks that bring procurement, quality, and clinical teams together to evaluate new tube variants under controlled protocols that mirror end-user workflows. Such frameworks should include standardized acceptance criteria for clot formation, hemolysis rates, and assay compatibility to streamline approval decisions across networked laboratories.

Second, pursue strategic supplier diversification and regional manufacturing partnerships to reduce exposure to trade disruptions. Where feasible, qualify secondary vendors through parallel validation tracks so that transitions can be managed with minimal clinical impact. Third, prioritize transparent technical documentation and analyzer compatibility matrices that simplify downstream validation for diagnostic customers and regulatory reviewers. Clear, data-driven product dossiers reduce time-to-approval and build trust with clinical adopters.

Finally, align product development investment with end-user pain points by co-designing tube features that improve automation compatibility, reduce hands-on processing time, and meet specific assay needs. By implementing these measures, leaders can improve operational resilience, accelerate adoption, and maintain high standards of analytical integrity across diverse laboratory environments.

Comprehensive research approach combining primary stakeholder interviews, technical dossier review, and validation-focused case studies to ensure actionable and reproducible insights

This research synthesizes primary interviews with clinical laboratory directors, procurement leaders, and manufacturing quality experts, supplemented by secondary review of technical literature, regulatory guidance documents, and product specification sheets. Primary engagements focused on laboratory workflows, validation requirements, and procurement decision criteria, capturing real-world constraints and preferences across a representative set of end users. Secondary sources provided contextual grounding for additive chemistries, material performance characteristics, and sterilization practices.

Analytical methods included qualitative thematic analysis of stakeholder interviews and a structured mapping of product attributes-such as material type, additive composition, and tube geometry-to common laboratory performance metrics including clot formation consistency and automation compatibility. Validation-focused case studies were examined to illustrate how switching events are managed operationally and to identify common acceptance thresholds. Finally, regional regulatory and procurement practices were compared through document analysis and supplier-sourced compliance dossiers to identify practical implications for cross-border adoption.

Collectively, these methods ensure a robust synthesis of practitioner experience and technical documentation, enabling readers to draw actionable conclusions about product selection, supplier qualification, and operational risk management.

Synthesis of clinical, operational, and supply chain implications highlighting why strategic validation, documentation, and sourcing are essential for reliable diagnostics

In conclusion, clotting tubes are a critical but often underappreciated component of the diagnostic value chain, where choices about material, tube design, and additive chemistry have concrete implications for assay performance, laboratory workflow efficiency, and supply continuity. The cumulative effect of technological innovation, regulatory nuance, and trade dynamics is reshaping how laboratories and suppliers approach product development, procurement, and validation. Organizations that proactively align cross-functional validation practices with supplier diversification strategies will be better positioned to maintain clinical reliability under shifting operational conditions.

Moreover, the trend toward automation and expanded assay menus increases the premium on design attributes that support consistent handling and minimal assay interference. Regional considerations further complicate adoption pathways, making localized regulatory and logistical strategies indispensable. By integrating rigorous technical documentation, collaborative validation frameworks, and resilience-oriented sourcing practices, stakeholders can reduce the friction of change and support high-quality diagnostic outcomes.

The path forward emphasizes evidence-based procurement, closer collaboration between clinical and supply chain stakeholders, and an active focus on additive and material innovation to meet the evolving demands of modern diagnostic laboratories.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Clotting Tube Market, by Material

  • 8.1. Glass
  • 8.2. Plastic

9. Clotting Tube Market, by Tube Type

  • 9.1. Closed System
  • 9.2. Open System

10. Clotting Tube Market, by Application

  • 10.1. Clinical Chemistry
    • 10.1.1. Cholesterol
    • 10.1.2. Glucose
    • 10.1.3. Uric Acid
  • 10.2. Coagulation Tests
    • 10.2.1. Activated Partial Thromboplastin Time
    • 10.2.2. Prothrombin Time
    • 10.2.3. Thrombin Time
  • 10.3. Immunoassays
    • 10.3.1. Hormone Assays
    • 10.3.2. Tumor Markers

11. Clotting Tube Market, by Additive

  • 11.1. Serum Clot Activator
    • 11.1.1. Micronized Silica
    • 11.1.2. Silicone-Coated
  • 11.2. Sodium Citrate

12. Clotting Tube Market, by Sales Channel

  • 12.1. Online
  • 12.2. Ofkine

13. Clotting Tube Market, by End User

  • 13.1. Academic & Reference Laboratories
  • 13.2. Diagnostic Laboratories
  • 13.3. Hospitals
  • 13.4. Research Institutes

14. Clotting Tube Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Clotting Tube Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Clotting Tube Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Clotting Tube Market

18. China Clotting Tube Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. A.N. PHARMA
  • 19.6. A.V. Consumables
  • 19.7. ACEE Tubes Pvt Ltd
  • 19.8. Ajosha Bioteknik Pvt Ltd
  • 19.9. Apex Bio-medicals
  • 19.10. BD (Becton, Dickinson and Company)
  • 19.11. BDK Life Science
  • 19.12. Bio-x
  • 19.13. Cardinal Health Inc.
  • 19.14. CML Biotech Pvt Ltd
  • 19.15. Diagnostic Care And Trading Pvt Ltd
  • 19.16. Fusion Biotech
  • 19.17. Greiner Bio-One
  • 19.18. Human Biomedicals LLP
  • 19.19. Labtech Disposables
  • 19.20. Levram Life Sciences Pvt Ltd
  • 19.21. MK Plast
  • 19.22. Nasmed Diagnostics Pvt. Ltd.
  • 19.23. Quantum Biomedicals
  • 19.24. Raj Biosis Private Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL CLOTTING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CLOTTING TUBE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CLOTTING TUBE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CLOTTING TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CLOTTING TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CLOTTING TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CLOTTING TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES CLOTTING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA CLOTTING TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CLOTTING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CLOTTING TUBE MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CLOTTING TUBE MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CLOTTING TUBE MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CLOTTING TUBE MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CLOTTING TUBE MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CLOTTING TUBE MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CLOTTING TUBE MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CLOTTING TUBE MARKET SIZE, BY CLOSED SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CLOTTING TUBE MARKET SIZE, BY CLOSED SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CLOTTING TUBE MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CLOTTING TUBE MARKET SIZE, BY OPEN SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CLOTTING TUBE MARKET SIZE, BY OPEN SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CLOTTING TUBE MARKET SIZE, BY CHOLESTEROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CLOTTING TUBE MARKET SIZE, BY CHOLESTEROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CLOTTING TUBE MARKET SIZE, BY CHOLESTEROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CLOTTING TUBE MARKET SIZE, BY GLUCOSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CLOTTING TUBE MARKET SIZE, BY GLUCOSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CLOTTING TUBE MARKET SIZE, BY GLUCOSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CLOTTING TUBE MARKET SIZE, BY URIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CLOTTING TUBE MARKET SIZE, BY URIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CLOTTING TUBE MARKET SIZE, BY URIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CLOTTING TUBE MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CLOTTING TUBE MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CLOTTING TUBE MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CLOTTING TUBE MARKET SIZE, BY PROTHROMBIN TIME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CLOTTING TUBE MARKET SIZE, BY PROTHROMBIN TIME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CLOTTING TUBE MARKET SIZE, BY PROTHROMBIN TIME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CLOTTING TUBE MARKET SIZE, BY THROMBIN TIME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CLOTTING TUBE MARKET SIZE, BY THROMBIN TIME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CLOTTING TUBE MARKET SIZE, BY THROMBIN TIME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CLOTTING TUBE MARKET SIZE, BY HORMONE ASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CLOTTING TUBE MARKET SIZE, BY HORMONE ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CLOTTING TUBE MARKET SIZE, BY HORMONE ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CLOTTING TUBE MARKET SIZE, BY TUMOR MARKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CLOTTING TUBE MARKET SIZE, BY TUMOR MARKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CLOTTING TUBE MARKET SIZE, BY TUMOR MARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CLOTTING TUBE MARKET SIZE, BY MICRONIZED SILICA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CLOTTING TUBE MARKET SIZE, BY MICRONIZED SILICA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CLOTTING TUBE MARKET SIZE, BY MICRONIZED SILICA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CLOTTING TUBE MARKET SIZE, BY SILICONE-COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CLOTTING TUBE MARKET SIZE, BY SILICONE-COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CLOTTING TUBE MARKET SIZE, BY SILICONE-COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CLOTTING TUBE MARKET SIZE, BY SODIUM CITRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CLOTTING TUBE MARKET SIZE, BY SODIUM CITRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CLOTTING TUBE MARKET SIZE, BY SODIUM CITRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CLOTTING TUBE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CLOTTING TUBE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CLOTTING TUBE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CLOTTING TUBE MARKET SIZE, BY OFKINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CLOTTING TUBE MARKET SIZE, BY OFKINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CLOTTING TUBE MARKET SIZE, BY OFKINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CLOTTING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CLOTTING TUBE MARKET SIZE, BY ACADEMIC & REFERENCE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CLOTTING TUBE MARKET SIZE, BY ACADEMIC & REFERENCE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CLOTTING TUBE MARKET SIZE, BY ACADEMIC & REFERENCE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CLOTTING TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CLOTTING TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CLOTTING TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CLOTTING TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CLOTTING TUBE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CLOTTING TUBE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CLOTTING TUBE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CLOTTING TUBE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CLOTTING TUBE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CLOTTING TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS CLOTTING TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS CLOTTING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA CLOTTING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA CLOTTING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA CLOTTING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA CLOTTING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CLOTTING TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CLOTTING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE CLOTTING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE CLOTTING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST CLOTTING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST CLOTTING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA CLOTTING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA CLOTTING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC CLOTTING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC CLOTTING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL CLOTTING TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN CLOTTING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN CLOTTING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. GCC CLOTTING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. GCC CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. GCC CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. GCC CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. GCC CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 193. GCC CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 194. GCC CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
  • TABLE 195. GCC CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, 2018-2032 (USD MILLION)
  • TABLE 197. GCC CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. GCC CLOTTING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION CLOTTING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION CLOTTING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS CLOTTING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS CLOTTING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. G7 CLOTTING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. G7 CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 223. G7 CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. G7 CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. G7 CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 226. G7 CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 227. G7 CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
  • TABLE 228. G7 CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, 2018-2032 (USD MILLION)
  • TABLE 230. G7 CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. G7 CLOTTING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. NATO CLOTTING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. NATO CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 234. NATO CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. NATO CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. NATO CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 237. NATO CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 238. NATO CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
  • TABLE 239. NATO CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 240. NATO CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, 2018-2032 (USD MILLION)
  • TABLE 241. NATO CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. NATO CLOTTING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL CLOTTING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES CLOTTING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES CLOTTING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA CLOTTING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA CLOTTING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA CLOTTING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA CLOTTING TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA CLOTTING TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA CLOTTING TUBE MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA CLOTTING TUBE MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA CLOTTING TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA CLOTTING TUBE MARKET SIZE, BY SERUM CLOT ACTIVATOR, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA CLOTTING TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA CLOTTING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)